ExPharmPro: an online Animal Simulator for Medical and Pharmacy Colleges
An educational e-learning application that simulates animal experiments in pharmacology has been launched in December last year by Elsevier India. ExPharmPro is an e-learning tool, which simulates various drugs’ action and reactions on animals without causing animal killing. Currently, this application is being used effectively at reputed Universities. ExPharPro has been conceived by Dr. R. Raveendran (Professor Pharmacology, JIPMER) and developed by Elsevier India. ExPharmPro is in accordance to the guidelines issued by Medical Council of India and Pharmacy Council of India. ExPharmPro is available in both offline and online versions.
For a FREE 30-day Trial, visit: www.expharmpro.com or call us at: +91-124- 4774255 or mail: firstname.lastname@example.org
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier’s online solutions include SciVerse ScienceDirect, SciVerse Scopus, Reaxys, MD Consult and Mosby’s Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai’s Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading publisher and information provider, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
Director, Marketing-South Asia,
Elsevier Health Sciences
+91 124 4774310